Probiotics are safe for most healthy adults, but certain groups face real and sometimes serious risks from taking them. People with weakened immune systems, critically ill patients, premature infants, and those with specific heart or gut conditions can develop dangerous infections from the very bacteria or yeast meant to help them. If you fall into one of these categories, probiotics aren’t just unhelpful; they can be genuinely harmful.
People With Weakened Immune Systems
Probiotics contain live microorganisms, and a healthy immune system keeps them in check. When your immune defenses are compromised, those same organisms can escape the gut and enter the bloodstream, causing bacteremia (bacteria in the blood) or fungemia (fungus in the blood). The FDA specifically flags people on anti-rejection medications after organ or stem cell transplants, those taking injectable immunosuppressive drugs for autoimmune diseases, anyone on chemotherapy or radiation, and people taking corticosteroids above a certain threshold as being at elevated risk.
This isn’t theoretical. A yeast-based probiotic has caused bloodstream fungal infections in critically ill patients, particularly those being fed through a tube or who have a central venous catheter. For someone whose immune system is already struggling, introducing billions of live organisms is a gamble that can go wrong fast.
ICU and Hospitalized Patients
The clearest evidence of probiotic danger comes from intensive care units. A study published in Nature Medicine tracked over 22,000 ICU patients across 5.5 years and found that those receiving a common probiotic had a dramatically higher rate of bloodstream infection. Among the 522 patients given the probiotic, 1.1% developed bacterial bloodstream infections, compared to just 0.009% of the patients who didn’t receive it. That’s roughly a 120-fold increase in risk.
Researchers confirmed the connection wasn’t coincidental. Genetic sequencing showed the bacteria found in patients’ blood were essentially identical to the strains in the probiotic capsules. The organisms had traveled from the gut to the bloodstream, likely by crossing the intestinal wall or contaminating central line catheters. In one patient, the bacteria had even developed a new mutation conferring antibiotic resistance, making the resulting infection harder to treat. The general population’s annual rate of this type of infection from probiotics is vanishingly small (0.00007%), which underscores how dramatically the risk changes in an ICU setting.
Premature and Very Low Birth Weight Infants
The FDA has issued a specific warning about giving probiotics to preterm infants. Live bacteria and yeast in probiotic products have caused bloodstream infections in very premature and very low birth weight babies, sometimes with severe outcomes. The American Academy of Pediatrics does not support routine probiotic use in preterm infants, particularly those born weighing less than about 2.2 pounds (1,000 grams).
No probiotic product has been approved by the FDA for use as a drug or biological product in infants. That means the products available haven’t gone through rigorous safety testing for this population, including testing for contamination with unintended organisms. Parents of premature infants should be aware that “natural” doesn’t mean safe for a baby whose immune system and gut barrier are still developing.
People With Heart Valve Disease
Probiotic bacteria, particularly Lactobacillus species, can in rare cases cause infective endocarditis, a serious infection of the heart’s inner lining or valves. A review of 82 patients who developed this condition from Lactobacillus found that 16% had a prosthetic (replacement) heart valve, and another 8.5% had congenital heart disease.
Having a prosthetic valve made the infection far more deadly. Patients with prosthetic valves who developed endocarditis were nearly eight times more likely to die than those without prosthetic valves. The presence of an artificial valve was independently associated with mortality even after accounting for other factors like shock and heart failure. If you have a mechanical or biological heart valve replacement, or known structural heart disease, this is a risk worth taking seriously.
People With Short Bowel Syndrome
Short bowel syndrome occurs when a significant portion of the small intestine has been removed or doesn’t function properly. This condition changes how bacteria behave in the gut, and probiotics can contribute to a dangerous buildup of certain acids. The FDA considers patients with short bowel syndrome to be among the populations at higher risk for probiotic-related adverse events, alongside immunocompromised patients and those with central venous catheters.
The shortened intestine alters how food is fermented, and adding large quantities of live bacteria to an already disrupted system can tip the balance further. For people managing this condition, the potential downsides of probiotics outweigh the uncertain benefits.
People With Small Intestinal Bacterial Overgrowth
Small intestinal bacterial overgrowth (SIBO) happens when too many bacteria colonize the small intestine, causing gas, bloating, and digestive discomfort. Adding more bacteria through probiotics can make things worse. Research has found that probiotic users with suspected SIBO were significantly more likely to test positive for bacterial overgrowth than non-users: 93.6% compared to 65.7%.
The mechanism appears to involve methane-producing bacteria specifically. Probiotic use within the prior month was independently linked to higher rates of methane-dominant overgrowth, which is associated with constipation-predominant symptoms. People dealing with unexplained bloating, brain fogginess, and excessive gas may actually be fueling their symptoms by taking probiotics, especially if untreated SIBO is the underlying cause.
People Taking Certain Medications
If you’re on immunosuppressive drugs, probiotics deserve extra caution. This includes medications commonly prescribed after organ transplants, drugs used for autoimmune conditions, and chemotherapy agents. The concern is straightforward: these drugs deliberately weaken your immune response, which is exactly the defense your body needs to keep probiotic organisms from becoming pathogenic.
The interaction isn’t like a typical drug-drug conflict where one medication changes how another is absorbed. Instead, the medication creates the vulnerable conditions under which live probiotic organisms can cause infection. If you’re on any therapy that suppresses your immune system, the decision to take probiotics should involve your care team.
People With Central Venous Catheters
A central venous catheter, the type of IV line placed in a large vein near the heart for long-term medication or nutrition, creates a direct pathway for bacteria to enter the bloodstream. Nearly all ICU patients who developed probiotic-related bloodstream infections in the Nature Medicine study had central lines. The probiotic organisms may have contaminated the line directly, entered through contact with stool containing the probiotic strain, or crossed through a compromised intestinal wall.
This risk factor often overlaps with others on this list, since central lines are common in ICU patients, people receiving chemotherapy, and those on long-term IV nutrition. But the catheter itself is an independent risk factor worth knowing about, regardless of why you have one.